Effect of Chemotherapy on Homologous Recombination Repair Ability
- Conditions
- ovarian carcinoma, tubal carcinoma, peritoneal carcinoma
- Registration Number
- JPRN-UMIN000049833
- Lead Sponsor
- The Jikei University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 35
Not provided
(1) Patients with contraindications to either paclitaxel or carboplatin. (2) Patients with poorly controlled cardiac disease, renal disease, or diabetes mellitus. (3) Patients with interstitial pneumonia or pulmonary fibrosis (to be confirmed by CT scan). (4) Patients with intestinal paralysis or intestinal obstruction that is poorly controlled. (5) Patients with infectious diseases requiring treatment. (6) Patients with a history of radiation therapy to the chest or abdomen. (7) Patients with active multiple cancers (not including intraepithelial cancer). (viii) Patients with a history of serious drug hypersensitivity. (9) Patients with symptomatic central nervous system metastasis. (10) Patients who are pregnant or lactating. (11) Patients who are currently receiving or have recently received other investigational drugs (including unapproved drugs). (12) Patients who are judged to be inappropriate to participate in this study by the investigators or co-investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method